From July 1, 2023 to September 30, 2023, the company has repurchased 1,072,041 shares, representing 2.2% for $50 million. With this, the company has completed the repurchase of 10,078,173 shares, representing 21.3% for $228.89 million under the buyback announced on November 8, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.46 USD | -0.47% | +3.28% | -31.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.35% | 2.07B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- AMPH Stock
- News Amphastar Pharmaceuticals, Inc.
- Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016.